| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.3M | — | +11.7% |
| Cost of Revenue | $7.1M | — | +11.4% |
| Gross Profit | $10.2M | — | +11.9% |
| R&D Expense | $1.6M | — | +21.0% |
| SG&A Expense | $12.1M | — | +7.7% |
| Operating Income | -$3.4M | — | -1.5% |
| Income Tax | $36K | — | — |
| Net Income | -$4.0M | — | -5.7% |
| EPS (Basic) | -$0.17 | — | +15.0% |
| EPS (Diluted) | -$0.17 | — | +15.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.5M | -33.2% | +92.2% |
| Accounts Receivable | $15.8M | +45.3% | +7.1% |
| Current Assets | $43.6M | -10.9% | +34.1% |
| Total Assets | $52.0M | -10.5% | +28.9% |
| Current Liabilities | $12.6M | -11.3% | -10.2% |
| Long-term Debt | $22.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.4M | — | +2.4% |
| Capital Expenditures | $228K | — | +101.8% |
| Investing Cash Flow | -$228K | — | -113.1% |
| Financing Cash Flow | -$62K | — | +3.1% |
| Free Cash Flow | -$10.6M | — | +1.3% |
| +9.2% |
| Total Liabilities | $37.5M | -7.5% | +10.7% |
| Stockholders' Equity | $14.4M | -17.3% | +125.4% |